NEURO2024

*Yuto Kubota^1,2, Eiji Shigetomi^1,2, Kozo Saito^1,2, Youichi Shinozaki^1,2, Kenji Tanaka³, Nobuhiko Ohno^4,5, Schuichi Koizumi^1,2 (1. Dept. Neuropharmacol., Interdisc. Grad. Sch. Med., Univ. of Yamanashi, Yamanashi, Japan, 2. Yamanashi GLIA center, Yamanashi, Japan, 3. Div. Brain sci., Sch. Med., Keio Univ., Tokyo, Japan, 4. Div. Histol. and Cell Biol., Dept. Anat., Jichi Med. Univ., Tochigi, Japan, 5. Div. Ultrast. res., NIPS, Aichi, Japan)

*Riku Kawanabe¹, Sawako Uchiyama¹, Makoto Tsuda¹ (1. Dept Mol and System Pharmacol, Grad Sch Pharma Sci, Kyushu Univ, Fukuoka, Japan)

*Mai Kawaguchi^1,2, Tetsuya Hirabayashi², Kohji Kasahara², Makoto Murakami¹ (1. Lab of Microenvironmental Metabolic Health Sciences, Grad Sch Med, Univ of Tokyo, Tokyo, Japan, 2. Ctr for Basic Technology Research, Tokyo Metro Inst of Med Sci, Tokyo, Japan)

*Hiroki Hoshino^1,2,3, Sano Fumikazu^1,2,4, Shigetomi Eiji^1,2, Takeuchi Hideyuki^5,6,7, Kanemura Hideaki³, Koizumi Schuichi^1,2 (1. Dept Neuropharmacol, Interdiscip Grad Sch Med, Univ of Yamanashi, Yamanashi, Japan, 2. Yamanashi GLIA Center, Yamanashi, Japan, 3. Dept Pediatr, Fac Med, Univ of Toho, Tokyo, Japan, 4. Dept Pediatr, Fac Med, Univ of Yamanashi, Yamanashi, Japan, 5. Dept Neuro and Stroke Med, Grad Sch Med, Univ of Yokohama Chity, Kanagawa, Japan, 6. Dept Neuro, Fac Med, Int Univ of Health and Walfare, Tochigi, Japan, 7. Center of Intractable Neurology Disease and Dementia, Int Univ of Health and Welfare Atami Hospital)